To investigate underlying mechanisms of thrombocytopenia in myelodysplastic syndrome (MDS), radiolabeled platelet studies were performed in 30 MDS patients with platelet counts less than 100 × 109/L. Furthermore, plasma thrombopoietin and glycocalicin index (a parameter of platelet or megakaryocyte destruction) were determined. Mean platelet life (MPL), corrected for the degree of thrombocytopenia, was reduced in 15 of 30 patients (4.3 ± 0.9 days [mean ± SD] vs 6.0 ± 1.3, P = .0003). Platelet production rate (PPR) was reduced in 25 of 30 patients (68 ± 34 × 109/d vs 220 ± 65, P
CITATION STYLE
Houwerzijl, E. J., Blom, N. R., Van Der Want, J. J. L., Louwes, H., Esselink, M. T., Smit, J. W., … De Wolf, J. T. M. (2005). Increased peripheral platelet destruction and caspase-3-independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients. Blood, 105(9), 3472–3479. https://doi.org/10.1182/blood-2004-06-2108
Mendeley helps you to discover research relevant for your work.